Sarcomas Clinical Trials
The University of Vermont Cancer Center has many trials focused on sarcoma research.
Study Title: A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator's Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas who Either Relapsed or were Refractory to Prior Non-Adjuvant Chemotherapy
Purpose: The purpose of this study is to determine the efficacy and safety of aldoxorubicin in subjects with metastatic, locally advanced, or unresectable soft tissue sarcomas.
|ClinicalTrials.gov Identifier: NCT02049905|
|Contact: Sam Cory (802) 656-9446|
|Institution Number: 14-408|
|Protocol Research Type: Industry Sponsored|
Last modified April 12 2016 09:04 AM